The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.
Lipid metabolism in cancer progression and therapeutic strategies
Open accessAbstract
Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy producers, signaling molecules, and source material for the biogenesis of cell membranes. The enhanced synthesis, storage, and uptake of lipids contribute to cancer progression. The rewiring of lipid metabolism in cancer has been linked to the activation of oncogenic signaling pathways and cross talk with the tumor microenvironment. The resulting activity favors the survival and proliferation of tumor cells in the harsh conditions within the tumor. Lipid metabolism also plays a vital role in tumor immunogenicity via effects on the function of the noncancer cells within the tumor microenvironment, especially immune‐associated cells. Targeting altered lipid metabolism pathways has shown potential as a promising anticancer therapy. Here, we review recent evidence implicating the contribution of lipid metabolic reprogramming in cancer to cancer progression, and discuss the molecular mechanisms underlying lipid metabolism rewiring in cancer, and potential therapeutic strategies directed toward lipid metabolism in cancer. This review sheds new light to fully understanding of the role of lipid metabolic reprogramming in the context of cancer and provides valuable clues on therapeutic strategies targeting lipid metabolism in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Chen, C.-L., Uthaya Kumar, D. B., Punj, V., Xu, J., Sher, L., Tahara, S. M., Hess, S., & Machida, K. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.004 · Cited by 388
RetractedZhang, H., FENG, Z., Huang, R., Xia, Z., Xiang, G., & Zhang, J. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2596 · Cited by 51
RetractedTargeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells
Suzuki, M., Cao, K., Kato, S. X., Komizu, Y., Mizutani, N., Tanaka, K., Arima, C., Tai, M.-C., Yanagisawa, K., Togawa, N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79775 · Cited by 49
RetractedLi, J., Liu, J., Liang, Z., He, F., Yang, L., Li, P., Jiang, Y., Wang, B., Zhou, C., Wang, Y., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.46 · Cited by 43
Self-citationRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
The mystery of membrane organization: composition, regulation and roles of lipid rafts
Sezgin, E., Levental, I., Mayor, S., & Eggeling, C. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.16 · Cited by 2,124
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
Sphingolipids and their metabolism in physiology and disease
Hannun, Y. A., & Obeid, L. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.107 · Cited by 2,051
Understanding the diversity of membrane lipid composition
Harayama, T., & Riezman, H. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.138 · Cited by 2,046
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,778
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Pascual, G., Avgustinova, A., Mejetta, S., Martín, M., Castellanos, A., Attolini, C. S.-O., Berenguer, A., Prats, N., Toll, A., Hueto, J. A., et al. (2017) · Nature · doi:10.1038/nature20791 · Cited by 1,437
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413
Acetyl coenzyme A: a central metabolite and second messenger
Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J. M., Madeo, F., & Kroemer, G. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.014 · Cited by 1,378
Sphingolipid metabolism in cancer signalling and therapy
Ogretmen, B. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.96 · Cited by 1,207
Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L. N., Karoly, E. D., Freeman, G. J., Petkova, V., Seth, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms7692 · Cited by 1,202
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Shimano, H., & Sato, R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.91 · Cited by 1,174
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S. D., Haemmerle, G., Lass, A., & Madeo, F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.018 · Cited by 1,132
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
Snaebjornsson, M. T., Janaki-Raman, S., & Schulze, A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.010 · Cited by 1,097
ATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
Regulation and function of mTOR signalling in T cell fate decisions
Chi, H. (2012) · Nature Reviews Immunology · doi:10.1038/nri3198 · Cited by 1,035
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
Ma, X., Bi, E., Lu, Y., Su, P., Huang, C., Liu, L., Wang, Q., Yang, M., Kalady, M. F., Qian, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.04.002 · Cited by 1,033
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature · doi:10.1038/nature17412 · Cited by 1,010
AMPK and SIRT1: a long-standing partnership?
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00745.2009 · Cited by 903
Kim, B. J., Nam, J. H., Kim, K. H., Joo, M., Ha, T. S., Weon, K. Y., Choi, S., Jun, J. Y., Park, E. J., Wie, J., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366306 · Cited by 886
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
Self-citationCellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
DeBerardinis, R. J., & Thompson, C. B. (2012) · Cell · doi:10.1016/j.cell.2012.02.032 · Cited by 858
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · Cancer Communications · doi:10.1186/s40880-018-0301-4 · Cited by 850
Wang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
Fatty acid transport protein 2 reprograms neutrophils in cancer
Veglia, F., Tyurin, V. A., Blasi, M., De Leo, A., Kossenkov, A. V., Donthireddy, L., To, T. K. J., Schug, Z., Basu, S., Wang, F., et al. (2019) · Nature · doi:10.1038/s41586-019-1118-2 · Cited by 751
Statin Use and Reduced Cancer-Related Mortality
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1214827 · Cited by 720
LXR signaling couples sterol metabolism to proliferation in the acquired immune response
Bensinger, S. J., Bradley, M. N., Joseph, S. B., Zelcer, N., Janssen, E. M., Hausner, M. A., Shih, R., Parks, J. S., Edwards, P. A., Jamieson, B. D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.052 · Cited by 711
Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
Cai, L., Sutter, B. M., Li, B., & Tu, B. P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.004 · Cited by 701
The interplay between cell signalling and the mevalonate pathway in cancer
Mullen, P. J., Yu, R., Longo, J., Archer, M. C., & Penn, L. Z. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.76 · Cited by 699
Comerford, S. A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A. K., Walters, H., Tantawy, M. N., Fu, A., Manning, H. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.020 · Cited by 681
Emerging roles of lipid metabolism in cancer metastasis
Luo, X., Cheng, C., Tan, Z., Li, N., Tang, M., Yang, L., & Cao, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0646-3 · Cited by 677
Zhang, Y., Kurupati, R., Liu, L., Zhou, X. Y., Zhang, G., Hudaihed, A., Filisio, F., Giles-Davis, W., Xu, X., Karakousis, G. C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.004 · Cited by 616
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., & Ochoa, A. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050715 · Cited by 609
MYC, Metabolism, Cell Growth, and Tumorigenesis
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 602
Orm family proteins mediate sphingolipid homeostasis
Breslow, D. K., Collins, S. R., Bodenmiller, B., Aebersold, R., Simons, K., Shevchenko, A., Ejsing, C. S., & Weissman, J. S. (2010) · Nature · doi:10.1038/nature08787 · Cited by 599
Hossain, F., Al-Khami, A. A., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0036 · Cited by 588
Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells
Li, J., Condello, S., Thomes-Pepin, J., Ma, X., Xia, Y., Hurley, T. D., Matei, D., & Cheng, J.-X. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.11.004 · Cited by 579
Self-citationLiang, J., Nagahashi, M., Kim, E. Y., Harikumar, K. B., Yamada, A., Huang, W.-C., Hait, N. C., Allegood, J. C., Price, M. M., Avni, D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.013 · Cited by 563
Kidani, Y., Elsaesser, H., Hock, M. B., Vergnes, L., Williams, K. J., Argus, J. P., Marbois, B. N., Komisopoulou, E., Wilson, E. B., Osborne, T. F., et al. (2013) · Nature Immunology · doi:10.1038/ni.2570 · Cited by 552
Su, P., Wang, Q., Bi, E., Ma, X., Liu, L., Yang, M., Qian, J., & Yi, Q. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2994 · Cited by 540
Svensson, R. U., Parker, S. J., Eichner, L. J., Kolar, M. J., Wallace, M., Brun, S. N., Lombardo, P. S., Van Nostrand, J. L., Hutchins, A., Vera, L., et al. (2016) · Nature Medicine · doi:10.1038/nm.4181 · Cited by 536
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Degirmenci, U., Wang, M., & Hu, J. (2020) · Cells · doi:10.3390/cells9010198 · Cited by 534
Fatty acid oxidation: An emerging facet of metabolic transformation in cancer
Ma, Y., Temkin, S. M., Hawkridge, A. M., Guo, C., Wang, W., Wang, X.-Y., & Fang, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.006 · Cited by 531
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Camarda, R., Zhou, A. Y., Kohnz, R. A., Balakrishnan, S., Mahieu, C., Anderton, B., Eyob, H., Kajimura, S., Tward, A., Krings, G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4055 · Cited by 528
Phospholipid Remodeling in Physiology and Disease
Wang, B., & Tontonoz, P. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114444 · Cited by 527
Metabolic landscape of the tumor microenvironment at single cell resolution
Xiao, Z., Dai, Z., & Locasale, J. W. (2019) · Nature Communications · doi:10.1038/s41467-019-11738-0 · Cited by 524
MYC: Connecting selective transcriptional control to global RNA production
Kress, T. R., Sabò, A., & Amati, B. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3984 · Cited by 521
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Pollak, M. N. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0263 · Cited by 507
Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression
Goossens, P., Rodriguez-Vita, J., Etzerodt, A., Masse, M., Rastoin, O., Gouirand, V., Ulas, T., Papantonopoulou, O., Van Eck, M., Auphan-Anezin, N., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.016 · Cited by 502
Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
Ackerman, D., & Simon, M. C. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.06.001 · Cited by 495
Prima, V., Kaliberova, L. N., Kaliberov, S., Curiel, D. T., & Kusmartsev, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612920114 · Cited by 494
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Tavazoie, M. F., Pollack, I., Tanqueco, R., Ostendorf, B. N., Reis, B. S., Gonsalves, F. C., Kurth, I., Andreu-Agullo, C., Derbyshire, M. L., Posada, J., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.026 · Cited by 476
Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
LoRusso, P. M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.0018 · Cited by 470
Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A., & Wu, M. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 469
Visentin, B., Vekich, J. A., Sibbald, B. J., Cavalli, A. L., Moreno, K. M., Matteo, R. G., Garland, W. A., Lu, Y., Yu, S., Hall, H. S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.023 · Cited by 463
Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal
Mills, E. L., & O'Neill, L. A. (2016) · European Journal of Immunology · doi:10.1002/eji.201445427 · Cited by 458
Guo, D., Reinitz, F., Youssef, M., Hong, C., Nathanson, D., Akhavan, D., Kuga, D., Amzajerdi, A. N., Soto, H., Zhu, S., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0102 · Cited by 452
Baek, A. E., Yu, Y.-R. A., He, S., Wardell, S. E., Chang, C.-Y., Kwon, S., Pillai, R. V., McDowell, H. B., Thompson, J. W., Dubois, L. G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00910-z · Cited by 427
Field, C. S., Baixauli, F., Kyle, R. L., Puleston, D. J., Cameron, A. M., Sanin, D. E., Hippen, K. L., Loschi, M., Thangavelu, G., Corrado, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.021 · Cited by 425
Lally, J. S. V., Ghoshal, S., DePeralta, D. K., Moaven, O., Wei, L., Masia, R., Erstad, D. J., Fujiwara, N., Leong, V., Houde, V. P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.020 · Cited by 410
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer
Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1235 · Cited by 403
Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation
Lee, C.-K., Jeong, S.-H., Jang, C., Bae, H., Kim, Y. H., Park, I., Kim, S. K., & Koh, G. Y. (2019) · Science · doi:10.1126/science.aav0173 · Cited by 400
Qiu, B., Ackerman, D., Sanchez, D. J., Li, B., Ochocki, J. D., Grazioli, A., Bobrovnikova-Marjon, E., Diehl, J. A., Keith, B., & Simon, M. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1507 · Cited by 394
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y.-Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392
Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer
Liu, Q., Luo, Q., Halim, A., & Song, G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.002 · Cited by 379
Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling
Huang, P., Nedelcu, D., Watanabe, M., Jao, C., Kim, Y., Liu, J., & Salic, A. (2016) · Cell · doi:10.1016/j.cell.2016.08.003 · Cited by 377
Wu, H., Han, Y., Rodriguez Sillke, Y., Deng, H., Siddiqui, S., Treese, C., Schmidt, F., Friedrich, M., Keye, J., Wan, J., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910698 · Cited by 373
Cui, M., Xiao, Z., Wang, Y., Zheng, M., Song, T., Cai, X., Sun, B., Ye, L., & Zhang, X. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1192 · Cited by 369
Pizer, E. S., Thupari, J. N., Han, W. F., Pinn, M. L., Chrest, F. J., Frehywot, G. L., Townsend, C. A., & Kuhajda, F. P. (2000) · PubMed · Cited by 366
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
Xu, D., Wang, Z., Xia, Y., Shao, F., Xia, W., Wei, Y., Li, X., Qian, X., Lee, J.-H., Du, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2183-2 · Cited by 360
Self-citation27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Wu, Q., Ishikawa, T., Sirianni, R., Tang, H., McDonald, J. G., Yuhanna, I. S., Thompson, B., Girard, L., Mineo, C., Brekken, R. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.006 · Cited by 358
SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond
DeBose-Boyd, R. A., & Ye, J. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.01.005 · Cited by 353
Guo, D., Prins, R. M., Dang, J., Kuga, D., Iwanami, A., Soto, H., Lin, K. Y., Huang, T. T., Akhavan, D., Hock, M. B., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000446 · Cited by 351
Al-Khami, A. A., Zheng, L., Del Valle, L., Hossain, F., Wyczechowska, D., Zabaleta, J., Sanchez, M. D., Dean, M. J., Rodriguez, P. C., & Ochoa, A. C. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1344804 · Cited by 346
Liu, C., Chikina, M., Deshpande, R., Menk, A. V., Wang, T., Tabib, T., Brunazzi, E. A., Vignali, K. M., Sun, M., Stolz, D. B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.017 · Cited by 345
Pacella, I., Procaccini, C., Focaccetti, C., Miacci, S., Timperi, E., Faicchia, D., Severa, M., Rizzo, F., Coccia, E. M., Bonacina, F., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720113115 · Cited by 344
Corbet, C., Pinto, A., Martherus, R., Santiago de Jesus, J. P., Polet, F., & Feron, O. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.003 · Cited by 336
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Sun, Z., Miller, R. A., Patel, R. T., Chen, J., Dhir, R., Wang, H., Zhang, D., Graham, M. J., Unterman, T. G., Shulman, G. I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2744 · Cited by 335
Phosphatidylinositol 3-kinase, growth disorders, and cancer
Goncalves, M. D., Hopkins, B. D., & Cantley, L. C. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1704560 · Cited by 327
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
Harel, M., Ortenberg, R., Varanasi, S. K., Mangalhara, K. C., Mardamshina, M., Markovits, E., Baruch, E. N., Tripple, V., Arama-Chayoth, M., Greenberg, E., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.012 · Cited by 324
Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis
Wang, B., Rong, X., Palladino, E. N. D., Wang, J., Fogelman, A. M., Martín, M. G., Alrefai, W. A., Ford, D. A., & Tontonoz, P. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.12.017 · Cited by 317
Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
Schlaepfer, I. R., Rider, L., Rodrigues, L. U., Gijón, M. A., Pac, C. T., Romero, L., Cimic, A., Sirintrapun, S. J., Glodé, L. M., Eckel, R. H., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0183 · Cited by 304
Ventura, R., Mordec, K., Waszczuk, J., Wang, Z., Lai, J., Fridlib, M., Buckley, D., Kemble, G., & Heuer, T. S. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.020 · Cited by 301
Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer
Li, J., Gu, D., Lee, S. S.-Y., Song, B., Bandyopadhyay, S., Chen, S., Konieczny, S. F., Ratliff, T. L., Liu, X., Xie, J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.168 · Cited by 297
Self-citationAn aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Chen, M., Zhang, J., Sampieri, K., Clohessy, J. G., Mendez, L., Gonzalez-Billalabeitia, E., Liu, X.-S., Lee, Y.-R., Fung, J., Katon, J. M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0027-2 · Cited by 293
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
Kopecka, J., Trouillas, P., Gašparović, A. Č., Gazzano, E., Assaraf, Y. G., & Riganti, C. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100670 · Cited by 291
Nomura, D. K., Lombardi, D. P., Chang, J. W., Niessen, S., Ward, A. M., Long, J. Z., Hoover, H. H., & Cravatt, B. F. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.05.009 · Cited by 270
Fritz, V., Benfodda, Z., Rodier, G., Henriquet, C., Iborra, F., Avancès, C., Allory, Y., de la Taille, A., Culine, S., Blancou, H., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1064 · Cited by 270
Roongta, U. V., Pabalan, J. G., Wang, X., Ryseck, R.-P., Fargnoli, J., Henley, B. J., Yang, W.-P., Zhu, J., Madireddi, M. T., Lawrence, R. M., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0126 · Cited by 265
Saddoughi, S. A., Gencer, S., Peterson, Y. K., Ward, K. E., Mukhopadhyay, A., Oaks, J., Bielawski, J., Szulc, Z. M., Thomas, R. J., Selvam, S. P., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201283 · Cited by 264
The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery
Xia, Y., Xie, Y., Yu, Z., Xiao, H., Jiang, G., Zhou, X., Yang, Y., Li, X., Zhao, M., Li, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.070 · Cited by 257
Li, J., Huang, Q., Long, X., Zhang, J., Huang, X., Aa, J., Yang, H., Chen, Z., & Xing, J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.039 · Cited by 256
Self-citationPeck, B., Schug, Z. T., Zhang, Q., Dankworth, B., Jones, D. T., Smethurst, E., Patel, R., Mason, S., Jiang, M., Saunders, R., et al. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0146-8 · Cited by 254
Liu, X., Liang, Y., Song, R., Yang, G., Han, J., Lan, Y., Pan, S., Zhu, M., Liu, Y., Wang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0838-5 · Cited by 252
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
Tracz-Gaszewska, Z., & Dobrzyn, P. (2019) · Cancers · doi:10.3390/cancers11070948 · Cited by 248
ATP citrate lyase: A central metabolic enzyme in cancer
Icard, P., Wu, Z., Fournel, L., Coquerel, A., Lincet, H., & Alifano, M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.010 · Cited by 244
Jeter, C. R., Yang, T., Wang, J., Chao, H.-P., & Tang, D. G. (2015) · Stem Cells · doi:10.1002/stem.2007 · Cited by 242
Budhu, A., Roessler, S., Zhao, X., Yu, Z., Forgues, M., Ji, J., Karoly, E., Qin, L., Ye, Q., Jia, H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.054 · Cited by 238
Self-citationMYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
Zirath, H., Frenzel, A., Oliynyk, G., Segerström, L., Westermark, U. K., Larsson, K., Munksgaard Persson, M., Hultenby, K., Lehtiö, J., Einvik, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222404110 · Cited by 235
The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
Raccosta, L., Fontana, R., Maggioni, D., Lanterna, C., Villablanca, E. J., Paniccia, A., Musumeci, A., Chiricozzi, E., Trincavelli, M. L., Daniele, S., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130440 · Cited by 230
Zhao, Y., Liu, Y., Lin, L., Huang, Q., He, W., Zhang, S., Dong, S., Wen, Z., Rao, J., Liao, W., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0820-2 · Cited by 230
Self-citationTadros, S., Shukla, S. K., King, R. J., Gunda, V., Vernucci, E., Abrego, J., Chaika, N. V., Yu, F., Lazenby, A. J., Berim, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3062 · Cited by 221
Comprehensive Review on Betulin as a Potent Anticancer Agent
Król, S. K., Kiełbus, M., Rivero-Müller, A., & Stepulak, A. (2015) · BioMed Research International · doi:10.1155/2015/584189 · Cited by 220
Beyoğlu, D., Imbeaud, S., Maurhofer, O., Bioulac-Sage, P., Zucman-Rossi, J., Dufour, J.-F., & Idle, J. R. (2013) · Hepatology · doi:10.1002/hep.26350 · Cited by 213
RUNX transcription factors: orchestrators of development
Mevel, R., Draper, J. E., Lie-a-Ling, M., Kouskoff, V., & Lacaud, G. (2019) · Development · doi:10.1242/dev.148296 · Cited by 211
Targeting phospholipase D in cancer, infection and neurodegenerative disorders
Brown, H. A., Thomas, P. G., & Lindsley, C. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.252 · Cited by 209
Flaveny, C. A., Griffett, K., El-Gendy, B. E.-D. M., Kazantzis, M., Sengupta, M., Amelio, A. L., Chatterjee, A., Walker, J., Solt, L. A., Kamenecka, T. M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.05.007 · Cited by 208
Regulator of Fatty Acid Metabolism, Acetyl Coenzyme A Carboxylase 1, Controls T Cell Immunity
Lee, J., Walsh, M. C., Hoehn, K. L., James, D. E., Wherry, E. J., & Choi, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302985 · Cited by 208
Pommier, A. J. C., Alves, G., Viennois, E., Bernard, S., Communal, Y., Sion, B., Marceau, G., Damon, C., Mouzat, K., Caira, F., et al. (2010) · Oncogene · doi:10.1038/onc.2010.30 · Cited by 206
Kondo, A., Yamamoto, S., Nakaki, R., Shimamura, T., Hamakubo, T., Sakai, J., Kodama, T., Yoshida, T., Aburatani, H., & Osawa, T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.006 · Cited by 206
Lipid Droplets as Immune Modulators in Myeloid Cells
den Brok, M. H., Raaijmakers, T. K., Collado-Camps, E., & Adema, G. J. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.01.012 · Cited by 203
Scaglia, N., Chisholm, J. W., & Igal, R. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006812 · Cited by 199
An Essential Requirement for the SCAP/SREBP Signaling Axis to Protect Cancer Cells from Lipotoxicity
Williams, K. J., Argus, J. P., Zhu, Y., Wilks, M. Q., Marbois, B. N., York, A. G., Kidani, Y., Pourzia, A. L., Akhavan, D., Lisiero, D. N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0382-t · Cited by 198
Blask, D. E., Sauer, L. A., Dauchy, R. T., Holowachuk, E. W., Ruhoff, M. S., & Kopff, H. S. (1999) · PubMed · Cited by 198
Bile Acids Activate YAP to Promote Liver Carcinogenesis
Anakk, S., Bhosale, M., Schmidt, V. A., Johnson, R. L., Finegold, M. J., & Moore, D. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.030 · Cited by 196
The α6β4 integrin promotes resistance to ferroptosis
Brown, C. W., Amante, J. J., Goel, H. L., & Mercurio, A. M. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201701136 · Cited by 194
Haeusler, R. A., Hartil, K., Vaitheesvaran, B., Arrieta-Cruz, I., Knight, C. M., Cook, J. R., Kammoun, H. L., Febbraio, M. A., Gutierrez-Juarez, R., Kurland, I. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6190 · Cited by 191
Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism
Cai, Y., Crowther, J., Pastor, T., Abbasi Asbagh, L., Baietti, M. F., De Troyer, M., Vazquez, I., Talebi, A., Renzi, F., Dehairs, J., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.003 · Cited by 190
Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances
Pyne, S., Adams, D. R., & Pyne, N. J. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.03.001 · Cited by 189
Inflammatory signaling cascades and autophagy in cancer
Monkkonen, T., & Debnath, J. (2018) · Autophagy · doi:10.1080/15548627.2017.1345412 · Cited by 186
Lipid signalling drives proteolytic rewiring of mitochondria by YME1L
MacVicar, T., Ohba, Y., Nolte, H., Mayer, F. C., Tatsuta, T., Sprenger, H.-G., Lindner, B., Zhao, Y., Li, J., Bruns, C., et al. (2019) · Nature · doi:10.1038/s41586-019-1738-6 · Cited by 185
Self-citationLi, X., Chen, Y.-T., Hu, P., & Huang, W.-C. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0797 · Cited by 184
Liu, Y., Zuckier, L. S., & Ghesani, N. V. (2010) · PubMed · Cited by 183
Singh, R., Yadav, V., kumar, S., & Saini, N. (2015) · Scientific Reports · doi:10.1038/srep17454 · Cited by 183
Kapitonov, D., Allegood, J. C., Mitchell, C., Hait, N. C., Almenara, J. A., Adams, J. K., Zipkin, R. E., Dent, P., Kordula, T., Milstien, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0664 · Cited by 182
Lipid metabolism and lung cancer
Merino Salvador, M., Gómez de Cedrón, M., Moreno Rubio, J., Falagán Martínez, S., Sánchez Martínez, R., Casado, E., Ramírez de Molina, A., & Sereno, M. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.001 · Cited by 182
Exogenous lipids promote the growth of breast cancer cells via CD36
Zhao, J., Zhi, Z., Wang, C., Xing, H., Song, G., Yu, X., Zhu, Y., Wang, X., Zhang, X., & Di, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.5864 · Cited by 182
Sheng, R., Chen, Y., Yung Gee, H., Stec, E., Melowic, H. R., Blatner, N. R., Tun, M. P., Kim, Y., Källberg, M., Fujiwara, T. K., et al. (2012) · Nature Communications · doi:10.1038/ncomms2221 · Cited by 179
Wang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.018 · Cited by 179
Xin, M., Qiao, Z., Li, J., Liu, J., Song, S., Zhao, X., Miao, P., Tang, T., Wang, L., Liu, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10020 · Cited by 177
Self-citationMa, M. K. F., Lau, E. Y. T., Leung, D. H. W., Lo, J., Ho, N. P. Y., Cheng, L. K. W., Ma, S., Lin, C. H., Copland, J. A., Ding, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.015 · Cited by 177
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
O'Callaghan, G., & Houston, A. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13331 · Cited by 176
Yamada, T., Sato, K., Komachi, M., Malchinkhuu, E., Tobo, M., Kimura, T., Kuwabara, A., Yanagita, Y., Ikeya, T., Tanahashi, Y., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308133200 · Cited by 176
Pencheva, N., Buss, C. G., Posada, J., Merghoub, T., & Tavazoie, S. F. (2014) · Cell · doi:10.1016/j.cell.2014.01.038 · Cited by 175
Coordination of Lipid Metabolism in Membrane Biogenesis
Nohturfft, A., & Zhang, S. C. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175344 · Cited by 175
ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment
Khwairakpam, A., Shyamananda, M., Sailo, B., Rathnakaram, S., Padmavathi, G., Kotoky, J., & Kunnumakkara, A. (2015) · Current Drug Targets · doi:10.2174/1389450115666141224125117 · Cited by 173
Ehmsen, S., Pedersen, M. H., Wang, G., Terp, M. G., Arslanagic, A., Hood, B. L., Conrads, T. P., Leth-Larsen, R., & Ditzel, H. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.104 · Cited by 173
Targeting liver X receptors in cancer therapeutics
Lin, C.-Y., & Gustafsson, J.-Å. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3912 · Cited by 172
Liu, Y.-Y., Gupta, V., Patwardhan, G. A., Bhinge, K., Zhao, Y., Bao, J., Mehendale, H., Cabot, M. C., Li, Y.-T., & Jazwinski, S. M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-145 · Cited by 171
Self-citationZong, Y., Zhang, C.-S., Li, M., Wang, W., Wang, Z., Hawley, S. A., Ma, T., Feng, J.-W., Tian, X., Qi, Q., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0163-6 · Cited by 171
Barceló-Coblijn, G., Martin, M. L., de Almeida, R. F. M., Noguera-Salvà, M. A., Marcilla-Etxenike, A., Guardiola-Serrano, F., Lüth, A., Kleuser, B., Halver, J. E., & Escribá, P. V. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115484108 · Cited by 170
von Roemeling, C. A., Marlow, L. A., Pinkerton, A. B., Crist, A., Miller, J., Tun, H. W., Smallridge, R. C., & Copland, J. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2764 · Cited by 169
Sounni, N. E., Cimino, J., Blacher, S., Primac, I., Truong, A., Mazzucchelli, G., Paye, A., Calligaris, D., Debois, D., De Tullio, P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.022 · Cited by 169
Britten, C. D., Garrett-Mayer, E., Chin, S. H., Shirai, K., Ogretmen, B., Bentz, T. A., Brisendine, A., Anderton, K., Cusack, S. L., Maines, L. W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2363 · Cited by 167
Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity
Ma, X., Bi, E., Huang, C., Lu, Y., Xue, G., Guo, X., Wang, A., Yang, M., Qian, J., Dong, C., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171576 · Cited by 165
Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
Göbel, A., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188351 · Cited by 164
The Functional Characterization of Long Noncoding RNA SPRY4-IT1 in Human Melanoma Cells
Mazar, J., Zhao, W., Khalil, A. M., Lee, B., Shelley, J., Govindarajan, S. S., Yamamoto, F., Ratnam, M., Aftab, M. N., Collins, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1863 · Cited by 163
Park, A., Lee, Y., Kim, M. S., Kang, Y. J., Park, Y.-J., Jung, H., Kim, T.-D., Lee, H. G., Choi, I., & Yoon, S. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01859 · Cited by 163
Jiang, L., Fang, X., Wang, H., Li, D., & Wang, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02927 · Cited by 159
Roles of sphingosine-1-phosphate signaling in cancer
Wang, P., Yuan, Y., Lin, W., Zhong, H., Xu, K., & Qi, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1014-8 · Cited by 157
Jabs, M., Rose, A. J., Lehmann, L., Taylor, J., Moll, I., Sijmonsma, T., Herberich, S. E., Sauer, S. W., Poschet, G., Federico, G., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.029733 · Cited by 154
Kelly, R. S., Heiden, M. G. V., Giovannucci, E. L., & Mucci, L. A. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1223 · Cited by 152
A Phosphorylation Cascade Controls the Degradation of Active SREBP1
Bengoechea-Alonso, M. T., & Ericsson, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807906200 · Cited by 150
Al-Khami, A. A., Hossain, F. M., Wyczechowska, D. D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-3-s2-o18 · Cited by 150
Lü, M., Zhu, W., Wang, X., Tang, J.-J., Zhang, K., Yu, G., Shao, W., Lin, Z., Wang, S.-H., Lu, L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.019 · Cited by 150
Self-citationSeguin, F., Carvalho, M. A., Bastos, D., Agostini, M., Zecchin, K. G., Alvarez-Flores, M. P., Chudzinski-Tavassi, A., Coletta, R. D., & Graner, E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.355 · Cited by 148
Sadowski, M. C., Pouwer, R. H., Gunter, J. H., Lubik, A. A., Quinn, R. J., & Nelson, C. C. (2014) · Oncotarget · doi:10.18632/oncotarget.2433 · Cited by 147
Ponnusamy, S., Selvam, S. P., Mehrotra, S., Kawamori, T., Snider, A. J., Obeid, L. M., Shao, Y., Sabbadini, R. A., & Öğretmen, B. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200244 · Cited by 147
LNMICC Promotes Nodal Metastasis of Cervical Cancer by Reprogramming Fatty Acid Metabolism
Shang, C., Wang, W. T., Liao, Y., Chen, Y., Liu, T., Du, Q., Huang, J., Liang, Y., Liu, J., Zhao, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2356 · Cited by 147
Self-citationZhang, C., Liu, J., Huang, G., Zhao, Y., Yue, X., Wu, H., Li, J., Zhu, J., Shen, Z., Haffty, B. G., et al. (2016) · Genes & Development · doi:10.1101/gad.283283.116 · Cited by 145
Self-citationOrlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Schcolnik‐Cabrera, A., Chávez-Blanco, A. D., Domínguez-Gómez, G., Taja‐Chayeb, L., Morales‐Bárcenas, R., Trejo‐Becerril, C., Pérez‐Cárdenas, E., González‐Fierro, A., & Dueñas‐González, A. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1471132 · Cited by 145
Hong, C., Duit, S., Jalonen, P., Out, R., Scheer, L., Sorrentino, V., Boyadjian, R., Rodenburg, K. W., Foley, E., Korhonen, L., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123729 · Cited by 142
Role of fatty acid binding proteins (FABPs) in cancer development and progression
McKillop, I. H., Girardi, C. A., & Thompson, K. J. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.06.001 · Cited by 140
Lipid Metabolism at the Nexus of Diet and Tumor Microenvironment
Peck, B., & Schulze, A. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.09.007 · Cited by 140
Ma, X., Aoki, T., Tsuruyama, T., & Narumiya, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0125 · Cited by 139
Li, X., Chen, Y., Josson, S., Mukhopadhyay, N. K., Kim, J., Freeman, M. R., & Huang, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070987 · Cited by 138
Pyne, N. J., McNaughton, M., Boomkamp, S. D., MacRitchie, N. A., Evangelisti, C., Martelli, A. M., Jiang, H., Ubhi, S., & Pyne, S. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.09.001 · Cited by 134
Furuya, H., Shimizu, Y., & Kawamori, T. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9304-1 · Cited by 133
Agostini, M., Almeida, L. Y., Bastos, D. C., Ortega, R. M., Moreira, F. S., Seguin, F., Zecchin, K. G., Raposo, H. F., Oliveira, H. C. F., Amoêdo, N. D., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1136 · Cited by 131
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma
Koul, D., Shen, R., Kim, Y., Kondo, Y., Lu, Y., Bankson, J. A., Ronen, S. M., Kirkpatrick, D. L., Powis, G., & Yung, W. K. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop058 · Cited by 130
Bauerschlag, D., Maass, N., Leonhardt, P., Verburg, F. A., Pecks, U., Zeppernick, F. A., Morgenroth, A., Mottaghy, F. M., Tolba, R. H., Meinhold-Heerlein, I. M., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0511-3 · Cited by 129
Zhang, Y., Sun, Y., Rao, E., Yan, F., Li, Q., Zhang, Y., Silverstein, K. A. T., Liu, S., Sauter, E., Cleary, M. P., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2689 · Cited by 129
Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas
Beckner, M. E., Fellows-Mayle, W. K., Zhang, Z., Agostino, N. R., Kant, J. A., Day, B. W., & Pollack, I. F. (2009) · International Journal of Cancer · doi:10.1002/ijc.24918 · Cited by 127
Kurabe, N., Hayasaka, T., Ogawa, M., Masaki, N., Ide, Y., Waki, M., Nakamura, T., Kurachi, K., Kahyo, T., Shinmura, K., et al. (2013) · Cancer Science · doi:10.1111/cas.12221 · Cited by 126
Schewe, M., Franken, P., Sacchetti, A., Schmitt, M., Joosten, R., Böttcher, R., van Royen, M. E., Jeammet, L., Payré, C., Scott, P. M., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.023 · Cited by 125
Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse
Cheng, J., Bai, A., Beckham, T. H., Marrison, S. T., Yount, C. L., Young, K., Lü, P., Bartlett, A. M., Wu, B. X., Keane, B. J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64791 · Cited by 124
Pisanu, M. E., Noto, A., Vitis, C. D., Morrone, S., Scognamiglio, G., Botti, G., Venuta, F., Diso, D., Jakopin, Ž., Padula, F., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.027 · Cited by 124
Mahdy, A. E. M., Cheng, J., Li, J., Elojeimy, S. N., Meacham, W. D., Turner, L. S., Bai, A., Gault, C. R., McPherson, A. S., Garcia, N., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.281 · Cited by 120
Self-citationLipid biology of the podocyte—new perspectives offer new opportunities
Fornoni, A., Merscher, S., & Kopp, J. B. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.87 · Cited by 120
Zaidi, N., Royaux, I. E., Swinnen, J. V., & Smans, K. A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0095 · Cited by 119
Menard, J. A., Christianson, H. C., Kucharzewska, P., Bourseau-Guilmain, E., Svensson, K. J., Lindqvist, E., Chandran, V. I., Kjellén, L., Welinder, C., Bengzon, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2831 · Cited by 118
Dysfunction of phospholipase Cγ in immune disorders and cancer
Koss, H., Bunney, T. D., Behjati, S., & Katan, M. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.09.004 · Cited by 115
Molecular Pathways: Sterols and Receptor Signaling in Cancer
Gabitova, L., Gorin, A., & Astsaturov, I. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0122 · Cited by 115
Ganesan, R., Mallets, E. R., & Gómez-Cambronero, J. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.006 · Cited by 113
Edmond, V., Dufour, F., Poiroux, G., Shoji, K. F., Malleter, M., Fouqué, A., Tauzin, S., Rimokh, R., Sergent, O., Penna, A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.55 · Cited by 110
Metadata
- Authors
- Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C., Zhao, Y., Qin, L., & Dong, Q.
- Venue
- MedComm
- Publisher
- Wiley
- Published
- 2020-12-24
- Volume
- 2
- Issue
- 1
- Pages
- 27-59
- ISSN
- 2688-2663 (ISSN-L)
- OpenAlex
- W3118120466
- Cited by
- 393
- References
- 324
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.